Medication errors: Causes, prevention and reduction

British Journal of Haematology

Volumn 116, Issue 2, 2002, Pages 255-265

  Allard, Jonathan ^a   Carthey, Jane ^a   Cope, Judith ^a   Pitt, Matthew ^a   Woodward, Suzette ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Active failures; Latent conditions; Medication errors; Systems theory

Indexed keywords

ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; CISPLATIN; DOXORUBICIN; NARCOTIC AGENT; THEOPHYLLINE DERIVATIVE; VINBLASTINE; XANTHINE DERIVATIVE;

BLOOD BANK; BLOOD TRANSFUSION; CALCULATION; DOSE CALCULATION; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG INFORMATION; DRUG OVERDOSE; EDUCATION PROGRAM; EQUIPMENT DESIGN; ERROR; EXPERIENCE; HUMAN; MEDICAL RESEARCH; MEDICAL SPECIALIST; MEDICAL STAFF; POLICY; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SAFETY; STANDARDIZATION; UNITED KINGDOM;

CLINICAL COMPETENCE; DRUG ADMINISTRATION ROUTES; DRUG ADMINISTRATION SCHEDULE; DRUG DELIVERY SYSTEMS; HUMANS; MEDICAL STAFF, HOSPITAL; MEDICATION ERRORS; PRESCRIPTIONS, DRUG; QUALITY CONTROL;

EID: 0036178456     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03272.x     Document Type: Review

References (99)

1. Common errors of drug administration in infants
2. Research in practice: How drug mistakes affect self-esteem
3. Accidental doxorubicin overdose
4. How the NHS can improve safety and learning. By learning free lessons from near misses
5. Frequency, consequences and prevention of adverse drug events
6. Using information technology to reduce rates of medication errors in hospitals
7. Incidence of adverse drug events and potential adverse drug events
8. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors
9. Patient risk factors for adverse drug events in hospitalized patients
10. The attributes of medical event reporting systems: Experience with a prototype medical event reporting system for transfusion medicine
11. The Australian Incident Monitoring study in intensive care: AIMS-ICU. An analysis of the first year of reporting
12. The collection and use of near miss data. Is 'no blame' just wishful thinking?
13. Some hopes, and concerns, regarding medical event reporting systems: Lessons from the NASA Aviation Safety Reporting System (ASRS)
14. Drug errors in intensive care
15. Prevention of medication errors. Developing a continuous quality improvement approach
16. Incidence of adverse events and negligence in hospitalized patients. Results from the Harvard medical practice study I
17. Human error and patient-controlled analgesia pumps
18. The relationship between a calculation test given in nursing orientation and medication errors
19. Fatal blood transfusion reactions. An analysis
20. Infusion confusion
21. Studies in cockpit task management errors
22. Massive cisplatin overdose by accidental substitution for carboplatin. Toxicity and management
23. Confirmation bias: Focus on narcotics accidents; Revia® and Revex® name confusion
24. Preventing medication errors in cancer chemotherapy
25. Draft guidelines for preventing medication errors in pediatrics
26. Overdose of vinblastine in a child with Langerhans' cell histiocytosis: Toxicity and salvage therapy
27. Gaps in the continuity of care and progress on patient safety
28. Make infusion pumps safer to use
29. That dreaded moment
30. New perspectives on preventing medication errors and adverse drug events
31. Look-a-like and sound-a-like drug names: The problem and the solution
32. A validated, reliable method of scoring the severity of medication errors
33. Radiotherapy errors could have damaged 492 patients
34. Experience with a national medication error reporting programme
35. Can we prevent cytotoxic disasters?
36. Intrathecal vincristine: An analysis of reasons for recurrent fatal chemotherapeutic error with recommendations for prevention
37. Is there a cure for drug errors?
38. Medication errors that have led to mans-laughter charges
39. Medication error prevention by clinical pharmacists in two children's hospitals
40. Practical approaches to improve laboratory performance and transfusion safety
41. Drug administration errors: A study into the factors underlying the occurrence and reporting of drug errors in a district general hospital
42. A continuous-improvement approach for reducing the number of chemotherapy related errors
43. The disturbing case of the cure that killed the patient
44. Transfusion associated fatalities. Review of Bureau of Biologics reports 1976-78
45. Intravenous medication errors
46. Comparing near misses with actual mistransfusion events: A more accurate reflection of transfusion errors
47. Accidental administration of vincristine into the brachial artery
48. Identification and classification of the causes of events in transfusion medicine
49. Pediatric medication errors: Predicting and preventing ten fold disasters
50. Errors in computing drug doses
51. Vincristine overdose: Experience with 3 patients
52. Teenage patient dies after doctors' injection mistake
53. The nature of adverse events in hospitalised patients. Results from the Harvard medical practice study II
54. Systems analysis of adverse drug events
55. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit
56. Intrathecal methotrexate overdose
57. Medication prescribing errors in a teaching hospital
58. Medication-prescribing errors in a teaching hospital. A 9 year experience
59. Applying human factors to the design of medical equipment: Patient controlled analgesia
60. Errors in transfusion medicine. Scope of the problem
61. An overview of state efforts to improve transfusion medicine. The New York model
62. A report of 104 transfusion errors in New York State
63. Transfusion errors in New York State. An analysis of 10 years experience
64. Errors in blood transfusion in Britain: A survey of hospital haematology departments
65. Accidental intrathecal vincristine administration. Report of a case
66. Increasing transfusion safety by reducing human error
67. A review of the national chemotherapy errors database and recommendations for safe administration
68. Potential salvage therapy for inadvertent intrathecal administration of vincristine
69. Can nurses do their sums?
70. Human error - A significant cause of transfusion mortality
71. Implementation of a rules based computerised bedside prescribing and administration system: Intervention study
72. Medication errors in neonatal and paediatric intensive care units
73. Medication errors during hospital ward rounds
74. Medication errors in a paediatric teaching hospital in the UK: Five years operational experience
75. Errors by paediatric residents in calculating drug doses
76. Preventing chemotherapy dose and scheduling errors
77. Chemotherapy medication errors: Descriptions, severity and contributing factors
78. People versus computers in medicine
79. The impact of shiftwork on personnel at a nuclear power plant: An exploratory survey study
80. Vincristine overdose in paediatric patients
81. Patient died after nurse's morphine tablet blunder
82. Errors in transfusion medicine. Detection, analysis, frequency and prevention
83. Errors involving patients receiving chemotherapy: A literature review
84. Avoiding drug errors. Reporting of errors should be free of recrimination
85. Reasons for not reporting adverse incidents: An empirical study
86. Drug errors and incidents in a neonatal intensive care unit. A quality assurance initiative
87. Serious hazards of transfusion (SHOT) initiative: Analysis of the first two annual reports
88. Medication errors in paediatric practice: Insights from a continuous quality improvement approach
89. An analysis of errors in blood component transfusion records with regard to quality improvement of data acquisition and to the performance of lookback and traceback procedures